Cancer Network » Breast Cancer
575 FOLLOWERS
Authoritative updates on the treatment of breast cancer for clinicians, including news on guidelines, mammography and screening, and comprehensive reviews on the management of triple-negative disease, and ER-, PR-, and HER2-positive disease. Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.
Cancer Network » Breast Cancer
4d ago
Virginia Kaklamani, MD, offers clinical insights on treatment toxicity considerations in HR+ breast cancer, and the Oncology Brothers outline key takeaways from the discussion ..read more
Cancer Network » Breast Cancer
4d ago
Heather Moore, CPP, PharmD, shares expert insights on the effective management of adverse effects related to tucatinib and other HER2 tyrosine kinase inhibitors (TKIs ..read more
Cancer Network » Breast Cancer
4d ago
Several presentations from the 41st Annual Miami Breast Cancer Conference focused on new and evolving data in the space, according to Neil M. Iyengar, MD ..read more
Cancer Network » Breast Cancer
4d ago
Several presentations from the 41st Annual Miami Breast Cancer Conference focused on new and evolving data in the space, according to Neil M. Iyengar, MD ..read more
Cancer Network » Breast Cancer
2w ago
Utidelone injection may cross the blood-brain barrier and help treat patients with breast cancer brain metastases ..read more
Cancer Network » Breast Cancer
2w ago
Data from the phase 3 TROPION-Breast01 trial support the biologics license application for datopotamab deruxtecan in hormone receptor–positive, HER2-negative breast cancer ..read more
Cancer Network » Breast Cancer
2w ago
Data from the NATALEE trial show that ribociclib may benefit a broad population of patients with early breast cancer who have an increased risk of recurrent disease ..read more
Cancer Network » Breast Cancer
3w ago
The phase 3 IMpassion030 trial did not find a survival benefit when atezolizumab was added to chemotherapy after surgery for patients with triple-negative breast cancer ..read more
Cancer Network » Breast Cancer
3w ago
Investigators will assess the PRE-ACT tool’s ability to predict adverse effects such as skin and heart damage in a phase 3 trial ..read more
Cancer Network » Breast Cancer
3w ago
Findings from the phase 3 CAPItello-291 trial support the approval of capivasertib/fulvestrant for patients with hormone receptor–positive, HER2-negative breast cancer in Japan ..read more